Opportunity overview
The East Midlands Pharmacy Collaborative (EMPC) (the "Authority") is issuing this Invitation to Tender ("ITT") in connection with the competitive procurement for the Provision of a HighTech Home Delivery Service for Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies (SACT).
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Alcura Healthcare Ltd
- Published award value
- Value not stated
- Awarded
- Not supplied
- Contract signed
- 18 Feb 2025
- Award ID
- 015430-2025-1
- Status
- active
- Identifier
- 02945457
- Location
- Northampton, UK, NN4 7PU, United Kingdom
HealthNet Homecare (UK) Limited
- Published award value
- Value not stated
- Awarded
- Not supplied
- Contract signed
- 18 Feb 2025
- Award ID
- 015430-2025-2
- Status
- active
- Location
- Swadlincote, UK, DE11 0WU, United Kingdom
B. Braun Medical Limited
- Published award value
- Value not stated
- Awarded
- Not supplied
- Contract signed
- 18 Feb 2025
- Award ID
- 015430-2025-3
- Status
- active
- Location
- Sheffield, UK, S35 2PW, United Kingdom
Sciensus Pharma Services Limited
- Published award value
- Value not stated
- Awarded
- Not supplied
- Contract signed
- 18 Feb 2025
- Award ID
- 015430-2025-4
- Status
- active
- Location
- Burton on Trent, UK, DE14 1SZ, United Kingdom
Pharmaxo Pharmacy Services Ltd
- Published award value
- Value not stated
- Awarded
- Not supplied
- Contract signed
- 18 Feb 2025
- Award ID
- 015430-2025-5
- Status
- active
- Location
- Corsham, UK, SN13 9FU, United Kingdom
LloydsPharmacy Clinical Homecare
- Published award value
- Value not stated
- Awarded
- Not supplied
- Contract signed
- 18 Feb 2025
- Award ID
- 015430-2025-6
- Status
- active
- Location
- Harlow, UK, CM19 5GU, United Kingdom
Classification
- CPV85100000 — Health services
Lots
- This Tender will review the use of Parenteral Chemotherapy (plus associated therapies) and for Parenteral Biologics Inc. Immunotherapies within the East Midlands and look to provide a cost/service improvement through an Open Tender process. This contract outlines the provision of a dispensing/compounding and delivery service to patients’ homes for Parenteral Chemotherapy plus associated treatments and for Parenteral Biologics plus nursing support where required, for administration for all products. Additional information: This is a Provider Selection Regime (PSR) Intention to Award Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt the provisions of the Public Contract Regulations 2015 do not apply to this award.<br/>This Contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.<br/>No Conflicts of Interest have been declared by any individual involved in this Tender and has been recorded on the Conflict of Interest register accordingly<br/>The Tender panel was members of the East<br/>Midlands Pharmacy Collaborative Procurement Team and the Homecare Leads from the member Purchasing Authorities.<br/>Quality and Innovation 25%<br/>Improving access, reducing health inequalities and facilitating choice 15%<br/>Integration, collaboration and Service Sustainability<br/>10%<br/>Social Value & Sustainability 10%<br/>Quality Total - 60%<br/>Value Total - 10%<br/>Price - 30%<br/>Total - 100%£2.8m